Clinical Trial Update: Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating sorafenib in combination with transarterial chemoembolization for HBV-infected patients with intermediate hepatocellula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Hepatocellular Carcinoma

Drugs mentioned

• Nexavar (sorafenib) (sorafenib)

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: PHENYTOIN/SORAFENIB [VA Drug Interaction], Liver Neoplasms | Phase 2 | Status: UNKNOWN